Daniel Lee Flynn Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

Daniel Lee Flynn is Chief Scientific Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 57,158 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2023, when has been sold 1,655 shares (Common Stock) at a price of $14.4 per share, resulting in proceeds of $23,832. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.2K

0% 3M change

0% 12M change

Total Value Held $0

Daniel Lee Flynn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 16 2023	SELL Open market or private sale	$23,832 $14.4 p/Share	1,655 Reduced 2.81%	57,158 Common Stock
Feb 16 2023	SELL Open market or private sale	$20,687 $15.1 p/Share	1,370 Reduced 2.28%	58,813 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	-	16,488 Added 21.5%	60,183 Common Stock
Jan 17 2023	SELL Open market or private sale	$51,039 $21.24 p/Share	2,403 Reduced 5.21%	43,695 Common Stock
Jun 16 2022	SELL Open market or private sale	$19,006 $10.75 p/Share	1,768 Reduced 3.69%	46,098 Common Stock
Feb 16 2022	SELL Open market or private sale	$12,362 $9.05 p/Share	1,366 Reduced 2.77%	47,866 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	20,500 Added 29.4%	49,232 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	11,100 Added 27.87%	28,732 Common Stock
Feb 16 2021	SELL Open market or private sale	$24,826 $48.87 p/Share	508 Reduced 7.22%	6,532 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	11,100 Added 38.63%	17,632 Common Stock

DLF

Daniel Lee Flynn

Chief Scientific Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH

Account